Abstract
Tracheobronchial injuries are uncommon, occuring in as few as 0.5% of patients following injury. The incidence is highest following penetrating neck and the lowest as 2% following blunt chest injury. While commonly presenting as immediately life threatening injuries, they may present in a more occult fashion with late onset of hemoptysis, recurrent pneumonia and/or “asthma.” Management must be immediately directed to securing the airway, which may require advanced bronchoscopic skills. Subsequent repair must take into account the severity of associated injuries and exact location and degree of airway disruption.
Current Respiratory Medicine Reviews
Title:Diagnosis and Management of Trauma to the Trachea and Bronchi
Volume: 11 Issue: 1
Author(s): Katherine Peters, Jessica Thunell and Riyad Karmy-Jones
Affiliation:
Keywords: Airway, bronchus, trachea, trauma.
Abstract: Tracheobronchial injuries are uncommon, occuring in as few as 0.5% of patients following injury. The incidence is highest following penetrating neck and the lowest as 2% following blunt chest injury. While commonly presenting as immediately life threatening injuries, they may present in a more occult fashion with late onset of hemoptysis, recurrent pneumonia and/or “asthma.” Management must be immediately directed to securing the airway, which may require advanced bronchoscopic skills. Subsequent repair must take into account the severity of associated injuries and exact location and degree of airway disruption.
Export Options
About this article
Cite this article as:
Peters Katherine, Thunell Jessica and Karmy-Jones Riyad, Diagnosis and Management of Trauma to the Trachea and Bronchi, Current Respiratory Medicine Reviews 2015; 11 (1) . https://dx.doi.org/10.2174/1573398X1101150706145419
DOI https://dx.doi.org/10.2174/1573398X1101150706145419 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Potential Role of Morus Alba Leaves Extract on the Brain of Mice Infected with Schistosoma Mansoni
CNS & Neurological Disorders - Drug Targets Synaptic Plasticity, Metaplasticity and Depression
Current Neuropharmacology New Pharmacological Approaches in Infants with Hypoxic-Ischemic Encephalopathy
Current Pharmaceutical Design Deciphering the Physiology Underlying the Rapid Clinical Effects of Perispinal Etanercept in Alzheimers Disease
Current Alzheimer Research Extracellular Vesicles as Innovative Tools for Assessing Adverse Effects of Immunosuppressant Drugs
Current Medicinal Chemistry Migraine Attack Treatment : A Tailor-made Suit, Not One Size Fits All
Recent Patents on CNS Drug Discovery (Discontinued) Nesfatin-1 and the Cardiovascular System: Central and Pheripheral Actions and Cardioprotection
Current Drug Targets Targeted Drug Delivery and Imaging Using Mobile Milli/Microrobots: A Promising Future Towards Theranostic Pharmaceutical Design
Current Pharmaceutical Design Calcium Homeostasis Following Traumatic Neuronal Injury
Current Neurovascular Research The Role of Sigma-1 Receptor, an Intracellular Chaperone in Neurodegenerative Diseases
Current Neuropharmacology Search and Rescue: Identification of Cannabinoid Actions Relevant for Neuronal Survival and Protection
Current Neuropharmacology Fe-S Proteins Acting as Redox Switch: New Key Actors of Cellular Adaptive Responses
Current Chemical Biology Heterocyclic Secretase Inhibitors for the Treatment of Alzheimer’s Disease: An Overview
Central Nervous System Agents in Medicinal Chemistry Triggers of Cell Death in the Developing Brain
Current Pediatric Reviews Palmitoylethanolamide in Homeostatic and Traumatic Central Nervous System Injuries
CNS & Neurological Disorders - Drug Targets Role of Methylene Blue in Trauma Neuroprotection and Neuropsychiatric Diseases
CNS & Neurological Disorders - Drug Targets Combined Treatment Fkt-Botulinum Toxin Type A (Btx-A) in Patients with Strumpell-Lorrain Disease
Current Pharmaceutical Design Subject Index to Volume 10
Current Pharmaceutical Design Neurotransmitters and Microglial-Mediated Neuroinflammation
Current Protein & Peptide Science Lysosomal Storage Diseases and the Blood-Brain Barrier
Current Pharmaceutical Design